» Articles » PMID: 37051302

An Immunoresponsive Three-dimensional Urine-tolerant Human Urothelial Model to Study Urinary Tract Infection

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Murine models of urinary tract infection (UTI) have improved our understanding of host-pathogen interactions. However, given differences between rodent and human bladders which may modulate host and bacterial response, including certain biomarkers, urothelial thickness and the concentration of urine, the development of new human-based models is important to complement mouse studies and to provide a more complete picture of UTI in patients.

Methods: We originally developed a human urothelial three-dimensional (3D) model which was urine tolerant and demonstrated several urothelial biomarkers, but it only achieved human thickness in heterogenous, multi-layered zones and did not demonstrate the comprehensive differentiation status needed to achieve barrier function. We optimised this model by altering a variety of conditions and validated it with microscopy, flow cytometry, transepithelial electrical resistance and FITC-dextran permeability assays to confirm tissue architecture, barrier integrity and response to bacterial infection.

Results: We achieved an improved 3D urine-tolerant human urothelial model (3D-UHU), which after 18-20 days of growth, stratified uniformly to 7-8 layers comprised of the three expected, distinct human cell types. The apical surface differentiated into large, CD227+ umbrella-like cells expressing uroplakin-1A, II, III, and cytokeratin 20, all of which are important terminal differentiation markers, and a glycosaminoglycan layer. Below this layer, several layers of intermediate cells were present, with a single underlying layer of CD271+ basal cells. The apical surface also expressed E-cadherin, ZO-1, claudin-1 and -3, and the model possessed good barrier function. Infection with both Gram-negative and Gram-positive bacterial classes elicited elevated levels of pro-inflammatory cytokines and chemokines characteristic of urinary tract infection in humans and caused a decrease in barrier function.

Discussion: Taken together, 3D-UHU holds promise for studying host-pathogen interactions and host urothelial immune response.

Citing Articles

Oral ciprofloxacin biofilm activity in a catheter-associated urinary tract infection model.

Abbott I, Anderson C, van Gorp E, Wallis S, Roberts J, Meletiadis J J Antimicrob Chemother. 2024; 80(2):413-426.

PMID: 39626168 PMC: 11787899. DOI: 10.1093/jac/dkae424.


Advances in experimental bladder models: bridging the gap between in vitro and in vivo approaches for investigating urinary tract infections.

Nissanka M, Dilhari A, Wijesinghe G, Weerasekera M BMC Urol. 2024; 24(1):206.

PMID: 39313789 PMC: 11418205. DOI: 10.1186/s12894-024-01590-w.


Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics.

Timm M, Russell S, Hultgren S Nat Rev Microbiol. 2024; 23(2):72-86.

PMID: 39251839 DOI: 10.1038/s41579-024-01092-4.


The effect of antibiotic selection on collateral effects and evolvability of uropathogenic .

James B, Reesaul H, Kashif S, Behruznia M, Meehan C, Domingo-Sananes M NPJ Antimicrob Resist. 2024; 2(1):19.

PMID: 39036800 PMC: 11254750. DOI: 10.1038/s44259-024-00037-4.


Multispecies bacterial invasion of human host cells.

Abell-King C, Pokhrel A, Rice S, Duggin I, Soderstrom B Pathog Dis. 2024; 82.

PMID: 38794885 PMC: 11180983. DOI: 10.1093/femspd/ftae012.


References
1.
Moll R, Achtstatter T, Becht E, Ittensohn M, Franke W . Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. Am J Pathol. 1988; 132(1):123-44. PMC: 1880621. View

2.
Ingber D . Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies?. Adv Sci (Weinh). 2020; 7(22):2002030. PMC: 7675190. DOI: 10.1002/advs.202002030. View

3.
Elliott T, Reed L, Slack R, Bishop M . Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. J Infect. 1985; 11(3):191-9. DOI: 10.1016/s0163-4453(85)92997-4. View

4.
Jaimes-Parra B, Valle-Diaz de la Guardia F, Arrabal-Polo M, Herrera-Imbroda B, Lara M, Machuca-Santa-Cruz F . Ex vivo construction of a novel model of bioengineered bladder mucosa: A preliminary study. Int J Urol. 2015; 23(1):85-92. DOI: 10.1111/iju.12963. View

5.
Kawai T, Akira S . The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11(5):373-84. DOI: 10.1038/ni.1863. View